Italian Panel Pushes Biosimilars for IMID Care
An Italian expert panel is urging broader biosimilar use, faster access to new therapies, and stronger real-world tracking to improve sustainable care for inflammatory diseases. Medscape News Europe
Take Your Experience to the Next Level
NewDownload our mobile app for a faster and better experience.
Comments
0U
Join the discussion
Sign in to leave a comment